Fromkin Andrew J.
Insider CIK 1341896 · RGDO Director · NONE President & CEO, Director · IMVT Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IMVT Immunovant, Inc. | M Exercise deriv | 2026-05-28 | 2026-05-29 | 16,260 | — | $0 | 0 | SEC↗ |
| IMVT Immunovant, Inc. | M Exercise deriv | 2026-05-28 | 2026-05-29 | 71,492 | — | $0 | 0 | SEC↗ |
| IMVT Immunovant, Inc. | M Exercise deriv | 2026-05-28 | 2026-05-29 | 77,181 | — | $0 | 0 | SEC↗ |
| IMVT Immunovant, Inc. | M Exercise deriv | 2026-05-28 | 2026-05-29 | 31,668 | — | $0 | 0 | SEC↗ |
| IMVT Immunovant, Inc. | M Exercise | 2026-05-28 | 2026-05-29 | 31,668 | $4.99 | $158.0K | 131,400 | SEC↗ |
| IMVT Immunovant, Inc. | M Exercise | 2026-05-28 | 2026-05-29 | 71,492 | $7.94 | $567.6K | 202,892 | SEC↗ |
| IMVT Immunovant, Inc. | M Exercise | 2026-05-28 | 2026-05-29 | 16,260 | $14.70 | $239.0K | 296,333 | SEC↗ |
| IMVT Immunovant, Inc. | S Sale | 2026-05-28 | 2026-05-29 | 11,483 | $32.64 | $374.8K | 284,850 | SEC↗ |
| IMVT Immunovant, Inc. | S Sale | 2026-05-28 | 2026-05-29 | 210,468 | $33.56 | $7.06M | 74,382 | SEC↗ |
| IMVT Immunovant, Inc. | M Exercise | 2026-05-28 | 2026-05-29 | 77,181 | $8.43 | $650.6K | 280,073 | SEC↗ |
| IMVT Immunovant, Inc. | A Award deriv | 2026-04-07 | 2026-04-09 | 7,061 | — | $0 | 7,061 | SEC↗ |
| IMVT Immunovant, Inc. | A Award | 2026-04-07 | 2026-04-09 | 13,880 | — | $0 | 99,732 | SEC↗ |
| IMVT Immunovant, Inc. | S Sale | 2025-12-01 | 2025-12-03 | 2,898 | $23.95 | $69.4K | 85,852 | SEC↗ |
| IMVT Immunovant, Inc. | S Sale | 2025-12-01 | 2025-12-03 | 19,351 | $23.14 | $447.8K | 88,750 | SEC↗ |
| IMVT Immunovant, Inc. | A Award deriv | 2025-04-01 | 2025-04-03 | 7,600 | — | $0 | 7,600 | SEC↗ |
| IMVT Immunovant, Inc. | A Award | 2025-04-01 | 2025-04-03 | 16,188 | — | $0 | 108,101 | SEC↗ |
| IMVT Immunovant, Inc. | S Sale | 2025-03-07 | 2025-03-11 | 1,384 | $19.96 | $27.6K | 91,913 | SEC↗ |
| IMVT Immunovant, Inc. | S Sale | 2025-03-07 | 2025-03-11 | 6,616 | $19.52 | $129.1K | 93,297 | SEC↗ |
| IMVT Immunovant, Inc. | A Award deriv | 2024-04-02 | 2024-04-04 | 4,690 | — | $0 | 4,690 | SEC↗ |
| IMVT Immunovant, Inc. | A Award | 2024-04-02 | 2024-04-04 | 11,255 | — | $0 | 99,913 | SEC↗ |
| IMVT Immunovant, Inc. | S Sale | 2023-12-01 | 2023-12-05 | 3,636 | $39.81 | $144.7K | 93,431 | SEC↗ |
| IMVT Immunovant, Inc. | S Sale | 2023-12-01 | 2023-12-05 | 4,773 | $40.46 | $193.1K | 88,658 | SEC↗ |
| IMVT Immunovant, Inc. | S Sale | 2023-12-01 | 2023-12-05 | 3,941 | $38.78 | $152.8K | 97,067 | SEC↗ |
| IMVT Immunovant, Inc. | A Award deriv | 2023-04-12 | 2023-04-14 | 16,260 | — | $0 | 16,260 | SEC↗ |
| IMVT Immunovant, Inc. | A Award | 2023-04-12 | 2023-04-14 | 12,523 | — | $0 | 101,008 | SEC↗ |
| IMVT Immunovant, Inc. | A Award deriv | 2022-08-17 | 2022-08-19 | 31,668 | — | $0 | 31,668 | SEC↗ |
| IMVT Immunovant, Inc. | A Award | 2022-08-17 | 2022-08-19 | 21,059 | — | $0 | 88,485 | SEC↗ |
| IMVT Immunovant, Inc. | A Award deriv | 2022-01-10 | 2022-01-12 | 71,492 | — | $0 | 208,973 | SEC↗ |
| IMVT Immunovant, Inc. | A Award | 2022-01-10 | 2022-01-12 | 21,726 | — | $0 | 67,426 | SEC↗ |
| IMVT Immunovant, Inc. | P Buy | 2021-08-10 | 2021-08-11 | 5,500 | $7.90 | $43.5K | 45,700 | SEC↗ |
| IMVT Immunovant, Inc. | A Award deriv | 2021-03-19 | 2021-03-23 | 23,300 | — | $0 | 23,300 | SEC↗ |
| IMVT Immunovant, Inc. | A Award | 2021-03-19 | 2021-03-23 | 15,500 | — | $0 | 40,200 | SEC↗ |
| IMVT Immunovant, Inc. | A Award deriv | 2020-05-15 | 2020-05-18 | 37,000 | — | $0 | 37,000 | SEC↗ |
| IMVT Immunovant, Inc. | A Award | 2020-05-15 | 2020-05-18 | 24,700 | — | $0 | 24,700 | SEC↗ |
| IMVT Immunovant, Inc. | A Award deriv | 2019-12-18 | 2019-12-20 | 77,181 | — | $0 | 77,181 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | D To issuer deriv | 2016-11-01 | 2016-11-03 | 15,500 | — | $0 | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | D To issuer deriv | 2016-11-01 | 2016-11-03 | 17,778 | — | $0 | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | D To issuer deriv | 2016-11-01 | 2016-11-03 | 17,695 | — | $0 | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | D To issuer deriv | 2016-11-01 | 2016-11-03 | 5,666 | — | $0 | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | U Tender | 2016-11-01 | 2016-11-03 | 11 | — | $0 | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | U Tender | 2016-11-01 | 2016-11-03 | 5 | — | $0 | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | A Award deriv | 2016-01-12 | 2016-01-14 | 17,778 | — | $0 | 17,778 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | A Award deriv | 2015-07-09 | 2015-07-13 | 15,500 | — | $0 | 15,500 | SEC↗ |
| RGDO Regado Biosciences Inc | A Award deriv | 2015-01-01 | 2015-01-05 | 159,261 | — | $0 | 159,261 | SEC↗ |
| RGDO Regado Biosciences Inc | A Award deriv | 2014-06-12 | 2014-06-16 | 51,000 | — | $0 | 51,000 | SEC↗ |
| NONE Radius Health, Inc. | A Award deriv | 2013-11-14 | 2013-11-18 | 2,427,133 | $3.45 | $8.37M | 2,427,133 | SEC↗ |